高估值下兩大問題遭詬病 東鵬飲料(605499.SH)跌超7%
格隆匯6月21日丨東鵬飲料今日盤中一度跌超7%報246元,市值984億元,市盈率(TTM)高達101倍。截至上週五,該股上市16個交易日中出現15個漲停板,最高價265.65元較IPO價格46.27元累漲474%。公司上週曾幾度提示風險稱,公司目前股票價格已嚴重背離公司基本面情況,也顯著高於行業平均水平,存在估值較高的風險。作為快消品企業,東鵬飲料產品結構單一、銷售區域集中一直被詬病。數據顯示,“東鵬特飲”作為公司的核心產品,近三年貢獻營收佔比分別為94.99%、95.11%與93.88%。雖然公司近年來陸續推出由柑檸檬茶等其他系列產品,但整體銷售規模依舊較小。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.